Page last updated: 2024-08-25

rosiglitazone and Asymmetric Diabetic Proximal Motor Neuropathy

rosiglitazone has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gluch-Lutwin, M; Librowski, T; Nawiesniak, B; Sałat, K1
Patel, SS; Udayabanu, M1
Brosius, FC; Feldman, EL; Kretzler, M; Pennathur, S; Sullivan, KA; Wiggin, TD1
Abraira, C; Davis, SN; Duckworth, W; Emanuele, N; Goldman, S; Hayward, R; Henderson, WG; Huang, GD; Marks, J; McCarren, M; Moritz, T; Reaven, PD; Reda, D; Vitek, ME; Warren, SR; Zieve, FJ1
Rennings, AJ; Smits, P; Stewart, MW; Tack, CJ1

Trials

2 trial(s) available for rosiglitazone and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Glucose control and vascular complications in veterans with type 2 diabetes.
    The New England journal of medicine, 2009, Jan-08, Volume: 360, Issue:2

    Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; United States; Veterans

2009
Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage.
    Diabetologia, 2010, Volume: 53, Issue:9

    Topics: Adult; Aged; Capillary Permeability; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Thiazolidinediones; Vasodilation

2010

Other Studies

3 other study(ies) available for rosiglitazone and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain.
    Neurological research, 2013, Volume: 35, Issue:9

    Topics: 3T3-L1 Cells; Analgesics; Animals; Antioxidants; Cell Death; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Aminobutyric Acid; Glucose; Hep G2 Cells; Humans; Hyperalgesia; Lipid Metabolism; Male; Mice; Motor Skills; Neuralgia; Pain Threshold; Pregabalin; Rosiglitazone; Terfenadine; Thiazolidinediones

2013
Effect of Urtica dioica on memory dysfunction and hypoalgesia in an experimental model of diabetic neuropathy.
    Neuroscience letters, 2013, Sep-27, Volume: 552

    Topics: Animals; Avoidance Learning; Blood Glucose; Body Weight; Diabetic Neuropathies; Drug Therapy, Combination; Insulin; Maze Learning; Memory Disorders; Mice; Pain Threshold; Phytotherapy; Plant Extracts; Plant Leaves; Polydipsia; Rosiglitazone; Streptozocin; Thiazolidinediones; Urtica dioica

2013
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.
    Endocrinology, 2008, Volume: 149, Issue:10

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Gene Expression; Genomics; Growth Hormone; Hyperalgesia; Hypoglycemic Agents; Male; Mice; Mice, Inbred DBA; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Promoter Regions, Genetic; Rosiglitazone; Thiazolidinediones

2008